Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,960 total articles
Evolution Petroleum Corporation announced its plan to release the fiscal third quarter 2026 financial and operating results on May 12, 2026, followed by a conference call with top executives on May 13, 2026. The company focuses on U.S. onshore oil and natural gas properties, aiming to maximize shareholder returns through diversified asset managemen…
The Boston Beer Company reported first quarter 2026 results showing a 4% decline in depletions and 6.9% decrease in shipments, with net revenue down 4.4%. Despite gross margin improving 100 basis points to 49.3%, the company incurred a substantial non-recurring pre-tax litigation expense of $216 million, resulting in a GAAP diluted loss per share o…
Ryman Hospitality Properties, Inc. (NYSE: RHP) announced record first quarter 2026 financial results driven by strong performance in its same-store Hospitality segment. The company reported record consolidated revenue of $664.6 million, net income of $69.4 million, and Adjusted EBITDAre of $219.3 million. The hospitality portfolio saw increased boo…
FinWise Bancorp reported Q1 2026 financial results, highlighting $1.7 billion in loan originations, up 38% year-over-year. Net income declined to $2.7 million with diluted EPS of $0.20, compared to previous periods. The quarter saw higher net interest income and margin, driven by growth in credit enhanced loans and strategic programs. However, elev…
Piedmont Realty Trust, a self-managed real estate investment company specializing in Class A office properties in U.S. Sunbelt markets, announced its financial and operational results for Q1 2026. The company has scheduled a conference call and webcast to discuss the quarter's performance and recent developments.
Cue Biopharma has entered an exclusive license agreement to develop and commercialize Ascendant-221, a Phase 2 clinical-stage dual-mechanism anti-IgE monoclonal antibody designed to treat allergic diseases. The company plans a global Phase 2b trial in food allergy after data expected in late 2026 from an ongoing study in chronic spontaneous urticar…
Comstock Inc., a clean energy technology company listed on NYSE American under ticker LODE, will hold its Q1 2026 earnings call and business update webinar on May 7, 2026. The company's CEO and CFO will present financial results and operational updates, followed by a Q&A session. The company focuses on extracting and recycling metals from under-uti…
Alta Equipment Group Inc., a leading North American equipment dealership, announced it will release its first quarter 2026 financial results on May 7 after market close, followed by a management conference call and webcast. The company provides material handling, construction, and environmental processing equipment through over 80 locations across …
CubeSmart reported its Q1 2026 operating results showing largely stable performance with same-store revenue growth turning positive. The company posted diluted EPS of $0.36 and adjusted funds from operations (FFO) per share of $0.63, both slightly down year-over-year. CubeSmart expanded its portfolio by opening a new development property in New Yor…
CooperCompanies, a leading global medical device company, announced it will release its financial results for the second quarter of 2026 on June 4, 2026. The company will host a conference call to discuss results and corporate updates following the release.
Mohawk Industries reported Q1 2026 net earnings of $117 million, with adjusted EPS of $1.90 on $2.7 billion in net sales, an 8% increase reported but a 2.6% decline on constant currency and days. The company benefited from productivity improvements and restructuring efforts, offsetting inflationary cost pressures and volume decreases, while the com…
LXP Industrial Trust has pre-leased its 1.2 million square foot speculative warehouse development in Phoenix to a U.S. subsidiary of a global logistics company, with a five-year lease starting December 2026. The project, costing approximately $122 million, is expected to generate an 8.0% development cash yield, marking a significant leasing milesto…
The Ensign Group, Inc. announced its first quarter 2026 results showing significant growth in earnings and revenue, with GAAP diluted EPS up 21.9% to $1.67 and adjusted EPS rising 21.7% to $1.85. The firm reported increased occupancy and skilled nursing revenue rates, expanded its healthcare operations portfolio with key acquisitions, and raised it…
Westwood Holdings Group, Inc. reported its Q1 2026 results showing growth in assets under management to $18.3 billion, driven by strong performance in Energy and Real Assets strategies and growth in ETFs and private energy secondaries funds. Quarterly revenues totaled $25.0 million, slightly down from the previous quarter but above last year's firs…
Resmed, a leader in health technology focused on sleep and breathing, announced the retirement of longtime CFO Brett Sandercock effective May 4, 2026. Aaron Bloomer, formerly CFO at Exact Sciences, will succeed him. The company reiterated its fiscal 2026 financial outlook, signaling stable operational expectations moving forward.
SI-BONE, Inc., a Nasdaq-listed medical device company specializing in procedural solutions for compromised bone, announced its participation in the 2026 BofA Securities Healthcare Conference with a scheduled fireside chat. The event offers management a platform to discuss company developments and engage with investors.
Aligos Therapeutics, a clinical stage biotechnology company specializing in therapies for liver and viral diseases, announced it will report its first quarter 2026 financial results on May 7, 2026, after the U.S. markets close. The company focuses on developing treatments for chronic hepatitis B, metabolic-associated steatohepatitis, obesity, and c…
Cue Biopharma announces the appointment of Shao-Lee Lin, M.D., Ph.D., as CEO, President, and Board Director to steer the company’s transition into a clinical-stage biopharmaceutical company. Dr. Lin brings over 25 years of experience leading biotech firms and advancing drug candidates. The company is progressing its lead autoimmune candidate, CUE-4…
Syntec Optics Holdings, Inc. successfully closed a $20 million underwritten public offering of 2,857,142 common shares priced at $7.00 each. The company plans to use the proceeds to acquire or invest in complementary businesses, technologies, products or assets, as well as for working capital, capital expenditures, and to optimize its capital struc…
Provident Financial Services, Inc. announced a quarterly cash dividend of $0.24 per common share payable on May 29, 2026, to shareholders of record as of May 15, 2026. Provident Financial Services is the holding company for Provident Bank, serving communities in New Jersey, Pennsylvania, and New York with banking, wealth management, and insurance s…
Cibus, Inc., an agricultural technology company specializing in gene editing plant traits, will report its first quarter 2026 financial results on May 14, 2026, followed by a conference call. The company focuses on developing traits to improve crop productivity, yield, and sustainability, licensing these traits to seed companies.
PEDEVCO Corp. (NYSE American: PED), an energy company specializing in strategic oil and gas assets mainly in the Rocky Mountain and Permian Basins, announced its first quarter 2026 financial results will be released prior to a conference call on May 14, 2026. The company recently completed a merger in October 2025, significantly expanding its asset…
Matrix Service Company, a leading engineering and construction firm for energy and industrial markets, announced that CFO Kevin Cavanah will leave the company after the filing of the fiscal 2026 Annual Report. The company has engaged an executive search firm to find a replacement. The departure is not due to disagreements on accounting or operation…
Trupanion, Inc., a leading pet medical insurance provider, reported its first quarter 2026 results showing 12% total revenue growth year-over-year to $384 million, driven largely by a 16% increase in subscription revenue. The company achieved net income of $4.9 million, a significant improvement from a net loss in Q1 2025, supported by strong adjus…
Larimar Therapeutics announced the publication of research demonstrating that treatment with their lead drug candidate, nomlabofusp, increases frataxin (FXN) levels in tissues relevant to Friedreich’s Ataxia (FA). These frataxin increases correlate between critical tissues and accessible peripheral tissues such as skin and buccal cells, supporting …
